Stem cells combined with islet transplant for diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests if umbilical cord stem cells can improve the success of islet cell transplants for people with diabetes whose own pancreas no longer makes enough insulin. It aims to help patients achieve better blood sugar control and reduce dangerous low blood sugar episodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 or type 2 diabetes and your pancreas makes very little or no insulin.
- Your average blood sugar (HbA1c) is 7% or higher.
- You have frequent or severe low blood sugar episodes despite insulin therapy.
- You are between 18 and 70 years old.
- You do not have active infections, serious heart or kidney disease, or a history of certain cancers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new stem cell treatment for people with type 2 diabetes that is difficult to control with standard medications. The treatment uses a special kind of stem cell to try to improve blood sugar levels.
This trial tests whether transplanting your own insulin-making cells (islets) can help control blood sugar if you have type 2 diabetes and your pancreas is not making enough insulin. The goal is to reduce or stop your need for insulin injections.
This trial tests whether lab-grown islet cells (pancreatic organoids) can help control blood sugar in people who develop diabetes after having most or all of their pancreas removed. If successful, this could reduce the need for insulin shots.
This trial tests a two-step transplant approach using immune-related stem cells and islet (pancreas insulin–making) cells in children and teens who have type 1 diabetes caused by a genetic immune problem. It aims to improve insulin control and protect other organs that are being affected by their immune system.
This study tests a new treatment called E-islet 01, which may help people with type 1 diabetes who have very low natural insulin production and have had dangerous low blood sugar events. The goal is to see if it is safe and can reduce those episodes.
This study tests if islet cells made from stem cells can be safely transplanted to help control blood sugar in people with diabetes. It may offer a new treatment option for those who need insulin.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.